ICMR gets Rs 2.5 crore CSR fund from Fortis Healthcare

Choubey said, "the Fortis Hospital has done a commendable job and I am sure this would inspire many."

Published On 2020-09-28 04:00 GMT   |   Update On 2020-09-28 04:00 GMT

New Delhi: Private sector medical service provider Fortis Healthcare handed over a cheque of Rs 2.5 crore to ICMR in the presence of Minister of State for Health and Family Welfare Shri Ashwini Kumar Choubey in his office.Fortis Healthcare's MD and CEO Dr Ashutosh Raghuvanshi, senior Vice President (Corporate Affairs and CSR) Manu Kapila, SRL's CEO Anand Kumar presented the cheque to the...

Login or Register to read the full article

New Delhi: Private sector medical service provider Fortis Healthcare handed over a cheque of Rs 2.5 crore to ICMR in the presence of Minister of State for Health and Family Welfare Shri Ashwini Kumar Choubey in his office.

Fortis Healthcare's MD and CEO Dr Ashutosh Raghuvanshi, senior Vice President (Corporate Affairs and CSR) Manu Kapila, SRL's CEO Anand Kumar presented the cheque to the Indian Council of Medical Research (ICMR) Director-General Prof (DR) Balram Bhargav and senior financial advisor Rajiv Roy.

Also Read: New Delhi: 33 private hospitals directed to reserve 80 percent ICU beds for COVID patients

At the event, Shri Choubey said that the ICMR has "established an outstanding parameter in the field of research". Not only in India, this institute one of the best research institutes in the world. Scientists have worked tirelessly day and night since day one of the Covid-19 pandemic."

He also said, "the Fortis Hospital has done a commendable job and I am sure this would inspire many."

Also Read: WBCERC Decisions: 3 hospitals fined for medical negligence, 1 nursing home for refusing patient

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News